MEP17408A - N-(heterociklil) benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensi - Google Patents

N-(heterociklil) benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensi

Info

Publication number
MEP17408A
MEP17408A MEP-174/08A MEP17408A MEP17408A ME P17408 A MEP17408 A ME P17408A ME P17408 A MEP17408 A ME P17408A ME P17408 A MEP17408 A ME P17408A
Authority
ME
Montenegro
Prior art keywords
group
optionally substituted
represent
sulphonamides
anticoagulants
Prior art date
Application number
MEP-174/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Jean-Michel Altenburger
Gerard Cremer
Gilbert Lassalle
Mostafa Matrougui
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MEP17408A publication Critical patent/MEP17408A/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
MEP-174/08A 2000-03-23 2001-03-22 N-(heterociklil) benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensi MEP17408A (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0003724A FR2806722B1 (fr) 2000-03-23 2000-03-23 Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique
YUP-670/02A RS50370B (sr) 2000-03-23 2001-03-22 N-(heterociklil)benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensi
PCT/FR2001/000861 WO2001070736A1 (fr) 2000-03-23 2001-03-22 N-(heterocyclyl)benzene-ou pyridine sulfonamides comme agents antithrombotiques et anticoagulantes

Publications (1)

Publication Number Publication Date
MEP17408A true MEP17408A (hr) 2010-06-10

Family

ID=8848428

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-174/08A MEP17408A (hr) 2000-03-23 2001-03-22 N-(heterociklil) benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensi

Country Status (35)

Country Link
US (1) US6680329B2 (hr)
EP (1) EP1268469B1 (hr)
JP (1) JP2003528098A (hr)
KR (1) KR100791693B1 (hr)
CN (1) CN1183128C (hr)
AR (1) AR029900A1 (hr)
AT (1) ATE269325T1 (hr)
AU (2) AU4661701A (hr)
BG (1) BG65863B1 (hr)
BR (1) BR0109385A (hr)
CA (1) CA2401637C (hr)
DE (1) DE60103868T2 (hr)
DK (1) DK1268469T3 (hr)
EA (1) EA004986B1 (hr)
EE (1) EE05084B1 (hr)
ES (1) ES2222358T3 (hr)
FR (1) FR2806722B1 (hr)
HK (1) HK1051537A1 (hr)
HR (1) HRP20020762B1 (hr)
HU (1) HUP0300695A2 (hr)
IL (2) IL151619A0 (hr)
IS (1) IS2304B (hr)
ME (1) MEP17408A (hr)
MX (1) MXPA02009276A (hr)
NO (1) NO324835B1 (hr)
PL (1) PL204660B1 (hr)
PT (1) PT1268469E (hr)
RS (1) RS50370B (hr)
SI (1) SI1268469T1 (hr)
SK (1) SK286687B6 (hr)
TR (1) TR200402343T4 (hr)
TW (1) TWI290141B (hr)
UA (1) UA71667C2 (hr)
WO (1) WO2001070736A1 (hr)
ZA (1) ZA200206996B (hr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
WO2004052291A2 (en) 2002-12-06 2004-06-24 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
US7750162B2 (en) 2004-04-19 2010-07-06 Daiso Co., Ltd. Process for preparation of nonnatural amino acid and intermediate thereof
EP1739077A4 (en) * 2004-04-19 2008-04-16 Daiso Co Ltd PROCESS FOR THE PRODUCTION OF NON-NATURAL AMINO ACIDS AND INTERMEDIATES THEREFOR
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
US8586748B2 (en) * 2008-04-09 2013-11-19 Boehringer Ingelheim International Gmbh 2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10
WO2009142984A1 (en) * 2008-05-22 2009-11-26 Boehringer Ingelheim International Gmbh Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
WO2011094496A2 (en) * 2010-01-28 2011-08-04 The Medicines Company Trypsin-like serine protease inhibitors, and their preparation and use
FR2981071B1 (fr) * 2011-10-10 2014-02-07 Centre Nat Rech Scient Synthese versatile et stereospecifique d'acides amines gamma,delta-insatures par la reaction de wittig

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2727410B1 (fr) * 1994-11-25 1996-12-20 Synthelabo Chlorures de sulfonyles, leur preparation et leur utilisation comme intermediaires de synthese
FR2728570B1 (fr) * 1994-12-23 1997-04-11 Synthelabo Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique
FR2756285B1 (fr) * 1996-11-22 1998-12-18 Synthelabo Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique
FR2756220B1 (fr) * 1996-11-27 1998-12-24 Lorraine Laminage Roue pour vehicule terrestre a moteur
FR2771094B1 (fr) * 1997-11-19 2000-02-04 Synthelabo Derives de piperidine-2-carboxylate, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
NO324835B1 (no) 2007-12-17
MXPA02009276A (es) 2003-05-23
KR100791693B1 (ko) 2008-01-03
EE200200540A (et) 2004-04-15
HUP0300695A2 (hu) 2003-07-28
BG65863B1 (bg) 2010-03-31
AU2001246617B2 (en) 2006-03-02
BR0109385A (pt) 2003-06-03
ATE269325T1 (de) 2004-07-15
YU67002A (sh) 2005-07-19
EA200200838A1 (ru) 2003-04-24
IS2304B (is) 2007-10-15
DK1268469T3 (da) 2004-10-11
HRP20020762B1 (en) 2005-02-28
HRP20020762A2 (en) 2003-12-31
IL151619A0 (en) 2003-04-10
ES2222358T3 (es) 2005-02-01
AR029900A1 (es) 2003-07-23
US6680329B2 (en) 2004-01-20
WO2001070736A1 (fr) 2001-09-27
SK13512002A3 (sk) 2003-03-04
DE60103868D1 (de) 2004-07-22
DE60103868T2 (de) 2005-06-09
IS6535A (is) 2002-08-30
PT1268469E (pt) 2004-10-29
KR20020081476A (ko) 2002-10-26
CN1183128C (zh) 2005-01-05
EE05084B1 (et) 2008-10-15
IL151619A (en) 2009-05-04
JP2003528098A (ja) 2003-09-24
FR2806722A1 (fr) 2001-09-28
PL204660B1 (pl) 2010-01-29
HK1051537A1 (en) 2003-08-08
UA71667C2 (uk) 2004-12-15
SI1268469T1 (en) 2004-10-31
TWI290141B (en) 2007-11-21
US20030207920A1 (en) 2003-11-06
NO20024496L (no) 2002-11-22
EP1268469A1 (fr) 2003-01-02
EA004986B1 (ru) 2004-10-28
AU4661701A (en) 2001-10-03
CA2401637C (en) 2009-11-10
ZA200206996B (en) 2003-09-01
TR200402343T4 (tr) 2004-12-21
NO20024496D0 (no) 2002-09-19
CA2401637A1 (en) 2001-09-27
RS50370B (sr) 2009-11-10
PL364988A1 (en) 2004-12-27
SK286687B6 (sk) 2009-03-05
CN1426407A (zh) 2003-06-25
FR2806722B1 (fr) 2002-05-17
BG107130A (bg) 2003-06-30
EP1268469B1 (fr) 2004-06-16

Similar Documents

Publication Publication Date Title
HRP20080664A2 (hr) Supstituirani piridinski herbicidi
DK0771197T3 (da) Anvendelse af heterocykliske forbindelser som dopamin-D3-ligander
DE59812455D1 (de) Fluorpyrazol-biphenylamide als fungizide
BG98740A (en) Substituted pyrazolylpyrazoles, methods for their preparation, preparation of intermediate products and the usage of the compounds as herbicides
ATE258930T1 (de) Dihydrobenzifurane
MEP17408A (hr) N-(heterociklil) benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensi
RS50229B (sr) Analozi vitamina d3
PE20050587A1 (es) Derivados de diazindol-dicarbonilo-piperazinilo como agentes antivirales
MEP26608A (hr) Derivati aminotiazola i njihova primjena kao liganda crf receptora
YU44301A (sh) 5ht1 antagonisti za antidepresantnu terapiju
DE60112960D1 (de) Kondensierte pyridoindolderivate
DE60207104D1 (de) 2-amino-4-heteroarylethyl-thiazolinderivate und ihre verwendung als hemmstoffe der induzierbaren no-synthase
DK1377574T3 (da) 6-phenylbenzonaphtyridiner
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
DK415789D0 (da) Tetracykliske antidepressive midler
HRP20010630B1 (hr) Derivati 4-heterociklil-sulfonamidil-6-metoksi-5-(2-metoksi-fenoksi)-2-piridil-pirimidina, njihova proizvodnja i upotreba kao endotelin receptor antagonista
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
NZ336091A (en) Aqueous disinfecting cleaning composition
ATE286887T1 (de) Antibakterielle mittel
TR200300551T2 (tr) Agrokimyasal kompozisyon
DK1104419T3 (da) N-substituerede azabicyloheptan-derivater, deres fremstilling og anvendelse
DE69300162T2 (de) 2-Amino-N-[[[4-(aminocarbonyl)pyrimidin-2-yl]amino]alkyl]-pyrimidin-4-carbonsäureamidderivate, ihre Herstellung und ihre Anwendung in der Therapeutica.
MXPA04004020A (es) Tien-3-ilsulfonilamino(tio)carbonil-triazolin(tio)onas substituidas.
ATE154601T1 (de) 4-amino-2-(hetero)aryl-butanamide verwenbar als 5-ht1a-antagonisten
AR026673A1 (es) Benzoilpirazoles sustituidos por 3-(4,5-dihidroisoxazol-3-ilo)